Page 38 - Mark Muro News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Brookings used those projections to see how growth differs from the baseline in different states. Tourism-heavy states, like Nevada, see the biggest percent differences. DC and Massachusetts may experience smaller changes to their employment growth because of the pandemic than other states, based on a new Brookings report. Mark Muro, senior fellow and policy director of the Metropolitan Policy Program at Brookings, and research assistant Yang You looked at how employment may change across the US over 10 years. The analysis is based on the Bureau of Labor Statistics' recent projections that co...

Op-ed: 1.8M Hoosiers struggled during pre-pandemic 'normal.' Now's the time to aim higher. Mark Muro and Robert Maxim, Indianapolis Star This is the new normal for high schoolers, nearly one year into the coronavirus pandemic Replay Video Indiana has momentum as it moves (knock on wood) beyond the worst of the pandemic.  As recently as December, the state’s employment level was just 1.4% below that of February 2020, good for the ninth-fastest rebound among states.  Enabling the rebound, meanwhile, has been the state’s expansive “make and move” manufacturing and logi...

A new analysis reveals the human toll of the failure to raise the minimum wage.

As President Biden promises to spur domestic production through a Buy America initiative and massive investments in infrastructure and clean energy, Indiana could struggle to capitalize. Its technology and labor shortcomings illustrate broader concerns about U.S. competitiveness and national security that are drawing attention from lawmakers in both parties.

Heartland factories losing ground as Biden readies manufacturing push David J. Lynch © Catalent/Catalent Catalent in Bloomington, Ind., will soon begin producing both Moderna and Johnson & Johnson coronavirus vaccines. On a 20-acre industrial site in Bloomington, Ind., tucked between a beer distributor and the local Social Security office, drugmaker Catalent is putting the finishing touches on automated production lines that will soon begin spitting out vials of two coronavirus vaccines. The core of a $120 million overhaul, the new lines are among the fastest such syst...